{'fraction_non_alphanumeric': 0.0210016155088853, 'fraction_numerical': 0.0, 'mean_word_length': 5.966292134831461, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
The prognostic role of systemic inflammation in patients undergoing resection of colorectal liver metastases: C‐reactive protein (CRP) is a strong negative prognostic biomarker

Systemic inflammation has been associated with poor survival in several tumor types, but has been less extensively studied in resectable metastatic disease. The aim of the present study was to evaluate the prognostic role of CRP in colorectal cancer patients with liver metastases (CRLM) compared to conventional tumor‐ and patient‐related clinicopathological features as well as other indicators of the systemic inflammatory response (SIR).